CON vs REGN · P/E 18, rev $1.90B vs P/E 14, rev $14.34B
Concentra Group Holdings Parent, Inc. (CON) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Concentra Group Holdings Parent, Inc. (CON) is a medical care facilities company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CON revenue for 2024-12-31 was $1.90B. Net income was $171.9M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. CON currently screens at market cap $3.18B and trailing P/E 17.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CON currently screens at market cap $3.18B and trailing P/E 17.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CON and REGN stock pages for the full models.
Not investment advice.